Video-assisted Thoracoscopic Surgery - Exparel Study
Pain, Postoperative
About this trial
This is an interventional treatment trial for Pain, Postoperative focused on measuring Video-assisted thoracoscopic surgery (VATS), Paravertebral blocks, Liposomal Bupivacaine (Exparel)
Eligibility Criteria
Inclusion Criteria:
- Age over 18 years and less than 80 years
- Undergoing video-assisted thoracoscopic surgery (VATS) procedure
- BMI less than 40
Exclusion Criteria:
- Unable to provide informed consent
- Non-English speaking
- Pregnant
- BMI greater than 40
- Video-assisted thoracoscopic surgery pleurodesis subjects
- Patients with pre-existing chronic pain
- Opioid tolerance
- Pain syndromes including fibromyalgia, regional pain syndrome or post therapeutic neuralgia in a thoracic distribution
- Allergy to the study medication
- Patients with infectious disease
- Patients with impaired coagulation
- Severe hepatic disease
- Incarcerated
Sites / Locations
- University of IowaRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Liposomal bupivacaine
Bupivacaine
The patient will receive an intercostal nerve block by the surgeon in the operating room after anesthetic has been administered. The surgeon will use thoracoscopic guidance to administer the intercostal nerve block. The medication used in this block will liposomal bupivacaine (Exparel).
The patient will receive a paravertebral block by the anesthesiologist staffing the pain service area within the hospital prior to surgery. This regional anesthesia will be done using ultrasound guidance. The medication used in this block will be plain bupivacaine with epinephrine.